India, April 22 -- A new study from the University of Barcelona suggests a promising way to treat fatty liver disease using medicines that already exist.
Researchers found that two drugs, pemafibrate and telmisartan, can greatly reduce fat in the liver in animal studies. When used together, they not only improved liver health but also helped lower the risk of heart-related problems.
During the study, led by Professor Marta Alegret and involving several research groups from Spain and Sweden, researchers tested pemafibrate (a drug that lowers fat in the blood) and telmisartan (a blood pressure medicine). Pemafibrate is currently used in Japan, while telmisartan is used worldwide. They used these drugs for the study as people with fatty live...